Laboratorios Richmond S.A.C.I.F. (BCBA:RICH)

Argentina · Delayed Price · Currency is ARS

1,330.00

+25.00 (1.92%)

Nov 2, 2026, 5:13 PM BRT

Market Cap	107.40B -12.2%
Revenue (ttm)	114.02B -22.3%
Net Income	12.50B -35.8%
EPS	154.85 -35.8%
Shares Out	80.75M
PE Ratio	8.59
Forward PE	n/a
Dividend	26.89 (2.02%)
Ex-Dividend Date	Jun 12, 2026

Volume	752
Open	1,340.00
Previous Close	1,305.00
Day's Range	1,305.00 - 1,385.00
52-Week Range	1,290.00 - 2,300.00
Beta	-0.56
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About BCBA:RICH

Laboratorios Richmond S.A.C.I.F., together with its subsidiaries, develops, manufactures, and sells pharmaceutical products in Latin America, Africa, Asia, and the Middle East. It offers antiretroviral drugs for the treatment of human immunodeficiency virus; oncology and oncohematology drugs; cardiometabolism drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs, such as analgesics, antipsychotics, antidepressants, anti-dementia, antiepileptics, and hypnot... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1959

Employees 620

Stock Exchange Buenos Aires Stock Exchange

Ticker Symbol RICH

Full Company Profile

Financial Performance

In 2025, BCBA:RICH's revenue was 126.73 billion, an increase of 4.95% compared to the previous year's 120.75 billion. Earnings were 3.09 billion, a decrease of -90.16%.

Financial Statements